This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...
Claude is being positioned as an enterprise “intelligence layer,” moving beyond chatbots toward agentic systems embedded in regulated drug development and operational workflows with auditability and ...
Bristol Myers Squibb has formed a broad partnership with Hengrui Pharma, paying $600 million upfront to advance 13 early-stage programs from across the two companies’ pipelines. The deal could be ...
Of the 13 programs that the companies will advance, four will come from Hengrui Pharma and four from Bristol Myers Squibb. The remaining five assets will be jointly discovered. Bristol Myers Squibb ...
Abstract: Recently, a severe danger has evolved regarding the explosion of Electric Vehicle (EV) batteries due to their thermal issues. A proficient system is employed for managing the operations of ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) (“BMS”) will acquire all of the ...
Something disturbing is happening to Peregrine Falcons in North America. Their numbers are heading downward for the first time since the 1960s and ’70s, when the birds were teetering at the edge of ...
US pharma major Bristol Myers Squibb (NYSE: BMY) today announced that the European Commission has granted approval to Sotyktu (deucravacitinib), alone or in combination with methotrexate, for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results